This UK study found that about a quarter of adults screen positive for a blood-injection-injury phobia, and these folks are twice as likely to report COVID-19 vaccine hesitancy. If this fear was poof, gone, about 1 in 10 cases of reported vaccine hesitancy might vanish too.

Oxford University has entered into a partnership with Astra Zeneca for the development of a coronavirus vaccine. AJP is Chair of UK Dept. Health and Social Care's (DHSC) Joint Committee on Vaccination & Immunisation (JCVI) but does not participate in discussions on COVID-19 vaccines, and is a member of the WHO'S SAGE. The views expressed in this paper do not necessarily represent the views of DHSC, JCVI, or WHO.

This is a well-conducted study with a large sample size that addresses an important issue related to public health. The study uses established measures and statistical techniques to examine the relationship between injection fears and vaccine hesitancy. Despite some limitations related to the cross-sectional design and reliance on self-reported data, the findings provide valuable insights into factors contributing to vaccine hesitancy. The disclosed conflict of interest related to Oxford University's partnership with AstraZeneca, while noteworthy, doesn't appear to directly compromise the study's methodology or significantly influence the results of this particular investigation.